Benchmarks · Retirement savings · 55–59 · Pharma & biotech

Retirement savings for Pharma & biotech professionals aged 55–59 in the U.S.

Balances across 401(k), 403(b), IRA and other retirement accounts.

Modeled estimate · federal survey data
Household-level figures: the underlying survey (Fed SCF) measures households, grouped by the reference person's age — combined for a couple, and they read high for a single person. Why, and how this changes as live data grows.
Median
$45K
Upper quarter
$406K
Top 10%
$1.5M

Half of Pharma & biotech professionals aged 55–59 in the U.S. have a retirement savings above $44,880. Reaching the upper quarter takes about $405,600, and the top 10% starts at $1,458,480 — roughly 32.5× the median. The lower quarter sits below $0, and the bottom 10% is under $0.

Where do you land against Pharma & biotech professionals aged 55–59 in the U.S.?
Type a rough net worth and see your percentile in a minute. No account needed to look.
See where you stand →

The full distribution

PercentileRetirement savingsWhat it means
Bottom 10%$09 in 10 are above this
Lower quarter$025th percentile
Median$44,880half above, half below
Upper quarter$405,60075th percentile
Top 10%$1,458,480only 1 in 10 is above this
Average (mean)$56,100pulled up by the top end — the median is the better "typical"
Free account · Pharma & biotech professionals aged 55–59 in the U.S.

Track where you stand against Pharma & biotech professionals aged 55–59 in the U.S..

This page is the cohort. An account adds you to it: type a rough figure and your percentile sits on your dashboard, kept current as the cohort moves, and you get this cohort's monthly update email. No bank connection needed to start. Connect accounts later for the exact number and the savings-rate, spending and income ranks.

Apple, Google or email · no card · delete any time

Just want the number? Try the percentile calculator — no signup, nothing leaves your browser.

Retirement savings by age

AgeLower quarterMedian retirement savingsUpper quarterTop 10%
22–25 →$0$0$5,408$27K
26–29 →$0$1,320$28K$85K
30–33 →$0$4,092$53K$181K
34–37 →$0$3,168$88K$319K
38–41 →$0$12K$135K$481K
42–45 →$0$29K$208K$687K
46–50 →$0$42K$270K$963K
50–54 →$0$41K$297K$1.3M
55–59$0$45K$406K$1.5M
60–64 →$0$50K$460K$1.7M
65 and over →$0$0$345K$1.7M

More for Pharma & biotech professionals aged 55–59 in the U.S.

Net worth →Income →Investments →Savings rate →Monthly spending →
Monthly update · Pharma & biotech professionals aged 55–59 in the U.S.

Get this cohort's numbers when they move.

One email on the 1st: the median and top-10% retirement savings for Pharma & biotech professionals aged 55–59 in the U.S., what changed since last month, and how many members joined. No account, no spam, one-click unsubscribe.

You'll get the current figures right away, then monthly. Keeping Up Inc, New York. Privacy.

Common questions

What is the median retirement savings for Pharma & biotech professionals aged 55–59 in the U.S.?
The median retirement savings for Pharma & biotech professionals aged 55–59 in the U.S. is $44,880. Half of this group is above that figure and half below.
What retirement savings puts you in the top 10% of Pharma & biotech professionals aged 55–59 in the U.S.?
About $1,458,480. The 90th percentile is the level only one in ten people in this group exceeds — roughly 32.5× the median.
Where do these numbers come from?
They are modeled percentile distributions fitted to this cohort from federal survey microdata — the Federal Reserve's 2025 Survey of Consumer Finances (released October 2026), the BLS Consumer Expenditure Survey, Census ACS and BLS wage data — and they blend toward anonymized, aggregated data from Keeping Up members as each cohort grows. Full methodology at keepingup.com/methodology.

How this is built. Percentiles are modeled for this cohort from federal survey microdata — the Federal Reserve's 2025 Survey of Consumer Finances (released October 2026), the BLS Consumer Expenditure Survey (2024), the Census American Community Survey and BLS Occupational Employment & Wage Statistics (May 2025) — with metro cost-of-living and wage adjustments. As Keeping Up members in this cohort grow, the band blends toward anonymized, aggregated live data (minimum cohort sizes apply; no individual is ever identifiable). Seeded figures are household-level, as in the SCF; live cohorts are individual-level. Amounts are in current dollars. Read the full methodology.

Last updated October 2026. Cohort: Pharma & biotech professionals aged 55–59 in the U.S.. Model sample basis: 80.